Cargando…
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy
BACKGROUND: The effect of pharmaceutical intervention to treat adverse events on quality of life (QOL) in outpatients receiving cancer chemotherapy is unclear. We investigated whether pharmaceutical intervention provided by pharmacists in collaboration with physicians improves QOL with outpatient ca...
Autores principales: | Fujii, Hironori, Ueda, Yukino, Hirose, Chiemi, Ohata, Koichi, Sekiya, Kumiko, Kitahora, Mika, Sadaka, Shiori, Yamamoto, Senri, Watanabe, Daichi, Kato-Hayashi, Hiroko, Iihara, Hirotoshi, Kobayashi, Ryo, Kaburaki, Miho, Matsuhashi, Nobuhisa, Takahashi, Takao, Makiyama, Akitaka, Yoshida, Kazuhiro, Hayashi, Hideki, Suzuki, Akio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889741/ https://www.ncbi.nlm.nih.gov/pubmed/35236407 http://dx.doi.org/10.1186/s40780-022-00239-w |
Ejemplares similares
-
Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy
por: Hirose, Chiemi, et al.
Publicado: (2020) -
Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias
por: Watanabe, Daichi, et al.
Publicado: (2023) -
Bevacizumab in Combination with TAS‐102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study
por: Fujii, Hironori, et al.
Publicado: (2019) -
One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis
por: Watanabe, Daichi, et al.
Publicado: (2022) -
Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy — a retrospective observational study
por: Fujii, Hironori, et al.
Publicado: (2021)